Browse the latest research summaries in the field of pharmacology for spinal cord injury patients and caregivers.
Showing 31-40 of 525 results
Frontiers in Neurology, 2024 • May 9, 2024
This case report describes a 31-year-old man who developed isolated unilateral brachial plexus injury following acute carbon monoxide (CO) poisoning. The patient presented with weakness and sensory de...
KEY FINDING: A 31-year-old man developed left brachial plexopathy after CO poisoning, confirmed by electrophysiological studies showing severe abnormalities in the upper and moderate abnormalities in the middle branches.
Frontiers in Pharmacology, 2024 • May 15, 2024
This editorial highlights the potential of natural products, medicinal foods, and herbal medicines in treating bone metabolism diseases and bone-related tumors. The included research articles explore ...
KEY FINDING: Tea-Seed Oil (TSO) contains components with antibacterial properties, potentially acting through pathways like PI3K-AKT and MAPK.
Arch Bone Jt Surg, 2024 • June 1, 2024
Spinal cord injury (SCI) is a complex and incurable condition causing significant damage. While advancements in managing SCI have improved, a complete treatment for humans remains elusive due to the i...
KEY FINDING: The pathophysiology of SCI consists of a two-phase process: the primary mechanical injury and the subsequent cascade of auto-destructive damages. This cascade leads to inflammation, hemorrhage, demyelination, axon disruption, apoptosis, and necrosis.
Genes & Diseases, 2024 • June 28, 2023
The study evaluated the efficacy and safety of NeuroWell, Deanxit, and their combination in treating mild-to-moderate depression through a randomized clinical trial. Results indicated that both NeuroW...
KEY FINDING: Both Deanxit and NeuroWell reduced the Hamilton anxiety scale and Hamilton depression scale scores compared to the placebo.
Obes Sci Pract, 2024 • July 23, 2024
This study explores health care providers' (HCPs) views about barriers to AOM use in persons living with SCI/D. HCPs described four main thematic barriers to AOM use in persons with SCI/D: (1) AOM sid...
KEY FINDING: HCPs identified AOM side effects (bowel problems, gastrointestinal distress, skin breakdown, muscle loss) as significant barriers due to potential exacerbation in SCI/D patients.
Journal of Musculoskeletal and Neuronal Interactions, 2024 • July 18, 2024
This paper presents a narrative review of research findings on the disturbance of the typical balance between muscles and bones caused by acute muscle paralysis from BTX, resulting in osteopenia and b...
KEY FINDING: BTX might exert a direct influence on bone resorption.
Frontiers in Pharmacology, 2024 • September 13, 2024
Boldine is an orally active alkaloid with good tolerability in rodents, showing efficacy across various animal models of disease or injury. Open connexin hemichannels (CxHC) are consistently found in ...
KEY FINDING: Boldine blocks connexin (Cx) hemichannels (HCs), and many of its effects in rodent models are attributed to this blockade.
Nanoscale Advances, 2024 • September 15, 2024
The study successfully developed a micellar thermosensitive hydrogel (MCPP-M-gel) encapsulating minocycline (MC) using PEG–PLGA copolymer for spinal cord injury (SCI) treatment. In vitro, MCPP-M-gel e...
KEY FINDING: MCPP-M-gel demonstrated favorable physico-mechanical properties and extended MC release over 72 hours in vitro without cytotoxic effects on neural crest-derived ectoderm mesenchymal stem cells (EMSCs).
PLoS ONE, 2024 • October 31, 2024
This study used concept mapping to explore and prioritize content for a medication self-management toolkit for adults with SCI/D, caregivers, and healthcare providers. The final concept map contained ...
KEY FINDING: The final concept map included eight clusters, each representing a key content area for the medication self-management toolkit.
European Journal of Case Reports in Internal Medicine, 2024 • October 10, 2024
This case study presents a respiratory rehabilitation treatment involving combined oxygen therapy (O2) administered by high flow cannula (HFC) and Venturi mask (VM) in a patient with cervical spinal c...
KEY FINDING: The combined protocol of nighttime oxygen with high flow cannula and daytime Venturi mask improves intensive motor training of patients.